DAB2IP coordinates both PI3K-Akt and ASK1 pathways for cell survival and apoptosis

被引:154
作者
Xie, Daxing [1 ,2 ]
Gore, Crystal [1 ]
Zhou, Jian [1 ]
Pong, Rey-Chen [1 ]
Zhang, Haifeng [3 ,4 ]
Yu, Luyang [3 ,4 ]
Vessella, Robert L. [5 ]
Min, Wang [3 ,4 ]
Hsieh, Jer-Tsong [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Urol, Dallas, TX 75390 USA
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Gen Surg, Wuhan 430030, Hubei, Peoples R China
[3] Yale Univ, Sch Med, Interdept Program Vasc Biol & Transplantat, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
[5] Univ Washington, Sch Med, Dept Urol, Seattle, WA 98195 USA
关键词
cell apoptosis; prostate cancer; signal transduction; ABERRANT PROMOTER METHYLATION; PROTEIN HDAB2IP GENE; PHOSPHATIDYLINOSITOL 3'-KINASE; PROSTATE-CANCER; KINASE B; ACTIVATION; EXPRESSION; INHIBITOR; 3-KINASE; PHOSPHORYLATION;
D O I
10.1073/pnas.0908458106
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
In metastatic prostate cancer (PCa) cells, imbalance between cell survival and death signals such as constitutive activation of phosphatidylinositol 3-kinase (PI3K)-Akt and inactivation of apoptosis-stimulated kinase (ASK1)-JNK pathways is often detected. Here, we show that DAB2IP protein, often down-regulated in PCa, is a potent growth inhibitor by inducing G(0)/G(1) cell cycle arrest and is proapoptotic in response to stress. Gain of function study showed that DAB2IP can suppress the PI3K-Akt pathway and enhance ASK1 activation leading to cell apoptosis, whereas loss of DAB2IP expression resulted in PI3K-Akt activation and ASK1-JNK inactivation leading to accelerated PCa growth in vivo. Moreover, glandular epithelia from DAB2IP(-/-) animal exhibited hyperplasia and apoptotic defect. Structural functional analyses of DAB2IP protein indicate that both proline-rich (PR) and PERIOD-like (PER) domains, in addition to the critical role of C2 domain in ASK1 activity, are important for modulating PI3K-Akt activity. Thus, DAB2IP is a scaffold protein capable of bridging both survival and death signal molecules, which implies its role in maintaining cell homeostasis.
引用
收藏
页码:19878 / 19883
页数:6
相关论文
共 40 条
[1]   Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha [J].
Alessi, DR ;
James, SR ;
Downes, CP ;
Holmes, AB ;
Gaffney, PRJ ;
Reese, CB ;
Cohen, P .
CURRENT BIOLOGY, 1997, 7 (04) :261-269
[2]   Regulation of cell death protease caspase-9 by phosphorylation [J].
Cardone, MH ;
Roy, N ;
Stennicke, HR ;
Salvesen, GS ;
Franke, TF ;
Stanbridge, E ;
Frisch, S ;
Reed, JC .
SCIENCE, 1998, 282 (5392) :1318-1321
[3]   Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy [J].
Chang, F ;
Lee, JT ;
Navolanic, PM ;
Steelman, LS ;
Shelton, JG ;
Blalock, WL ;
Franklin, RA ;
McCubrey, JA .
LEUKEMIA, 2003, 17 (03) :590-603
[4]   Down-regulation of human DAB2IP gene expression mediated by polycomb Ezh2 complex and histone deacetylase in prostate cancer [J].
Chen, H ;
Tu, SW ;
Hsieh, JT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (23) :22437-22444
[5]   Epigenetic regulation of a novel tumor suppressor gene (hDAB2IP) in prostate cancer cell lines [J].
Chen, H ;
Toyooka, S ;
Gazdar, AF ;
Hsieh, JT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (05) :3121-3130
[6]  
Choe G, 2003, CANCER RES, V63, P2742
[7]  
Darzynkiewicz Z, 1996, CYTOMETRY, V25, P1
[8]   Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery [J].
Datta, SR ;
Dudek, H ;
Tao, X ;
Masters, S ;
Fu, HA ;
Gotoh, Y ;
Greenberg, ME .
CELL, 1997, 91 (02) :231-241
[9]   Signal transduction by the JNK group of MAP kinases [J].
Davis, RJ .
CELL, 2000, 103 (02) :239-252
[10]   Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in breast cancer [J].
Dote, H ;
Toyooka, S ;
Tsukuda, K ;
Yano, M ;
Ouchida, M ;
Doihara, H ;
Suzuki, M ;
Chen, H ;
Hsieh, JT ;
Gazdar, AF ;
Shimizu, N .
CLINICAL CANCER RESEARCH, 2004, 10 (06) :2082-2089